News

Filter

Current filters:

None

Popular Filters

76 to 100 of 8761 results

Merck Serono to establish production of Rebif in Russia

Merck Serono to establish production of Rebif in Russia

03-07-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA, plans to establish production of its multiple…

BiotechnologyMerck KGaAMerck SeronoNeurologicalPharmstandardProductionRebifRussia

Opportunities ripe for Pharma in Ghana and Nigeria

03-07-2014

Strong business opportunities exist for big pharmaceutical and generic pharmaceutical companies in Ghana…

HealthcareMarkets & MarketingPharmaceutical

Bio-Techne to acquire Novus Biologicals

03-07-2014

USA-based Techne Corp (d/b/a Bio-Techne) has acquired Novus Biologicals for $60 million in cash. The…

Bio-TechneBiotechnologyMergers & AcquisitionsNovus Biologicals

Isis Pharma earns $1 million GSK milestone on hepatitis B virus program

Isis Pharma earns $1 million GSK milestone on hepatitis B virus program

03-07-2014

USA-based Isis Pharmaceuticals has earned yet another $1 million payment from UK pharma giant GlaxoSmithKline,…

Anti-viralsFinancialGlaxoSmithKlineIsis PharmaceuticalsPharmaceuticalResearch

JAMA study shows bone marrow transplants can reverse sickle cell disease

03-07-2014

Bone marrow transplants can reverse severe sickle cell disease in adults, according to new data published…

HematologyPharmaceuticalResearchUSA

New OECD data shows Australia lagging in investing in medicines

New OECD data shows Australia lagging in investing in medicines

03-07-2014

Data newly released by the Organization for Economic Cooperation and Development (OECD) reveals that…

AustraliaFinancialHealthcarePharmaceutical

Eisai’s breast cancer drug Halaven receives MAA in Europe

Eisai’s breast cancer drug Halaven receives MAA in Europe

03-07-2014

The European Commission has issued Marketing Authorization Approval (MAA) for Halaven (eribulin) from…

EisaiEuropeHalavenOncologyPharmaceuticalRegulation

FDA orphan status for Insys’ cannabidiol as treatment for Dravet syndrome

FDA orphan status for Insys’ cannabidiol as treatment for Dravet syndrome

03-07-2014

US specialty pharma firm Insys Therapeutics yesterday revealed that the US Food and Drug Administration…

cannabidiolInsys TherapeuticsNeurologicalPharmaceuticalRare diseasesRegulationUSA

FDA accepts Boehringer’s nintedanib NDA; granted priority review for IPF

FDA accepts Boehringer’s nintedanib NDA; granted priority review for IPF

02-07-2014

The US subsidiary of German family-owned drug major Boehringer Ingelheim says that the New Drug Application…

Boehringer IngelheimnintedanibPharmaceuticalRegulationRespiratory and PulmonaryUSA

Salix leaps on positive Ph III results with Xifaxan in IBS-D

Salix leaps on positive Ph III results with Xifaxan in IBS-D

02-07-2014

US drugmaker Salix Pharmaceuticals’ saw its shares leap as much as 13% after the company released new…

Gastro-intestinalsPharmaceuticalResearchrifaximinSalix PharmaceuticalsXifaxan

USA’s GPhA and numerous other groups lodge concerns on biosimilars names

USA’s GPhA and numerous other groups lodge concerns on biosimilars names

02-07-2014

A total of 32 organizations have signed a letter calling on the US Food and Drug Administration to require…

BiosimilarsBiotechnologyRegulationUSA

Novartis takes action as former employee is arrested in Japan

Novartis takes action as former employee is arrested in Japan

02-07-2014

Swiss drug major Novartis (NOVN: VX) said yesterday that Novartis Pharma K.K. (NPKK) understands that…

JapanLegalNovartisPharmaceutical

NicOx to acquire Aciex Therapeutics

02-07-2014

Ophthalmology-focused French biotech firm NicOx has entered into an agreement to acquire all of the outstanding…

Aciex TherapeuticsBiotechnologyInflammatory diseasesMergers & AcquisitionsNicOxOphthalmics

Pozen re-files for US approval of PA8140/PA32540

Pozen re-files for US approval of PA8140/PA32540

02-07-2014

US drug firm Pozen has resubmitted the New Drug Application for PA8140/PA32540 (aspirin and omeprazole)…

AspirinCardio-vascularOmeprazolePA8140/PA32540PharmaceuticalPozenRegulationUSA

US FDA outlines expectations for human drug compounders

US FDA outlines expectations for human drug compounders

02-07-2014

Yesterday, the US Food and Drug Administration issued several policy documents regarding compounded drug…

PharmaceuticalRegulationUSA

UK launches fresh fight against antimicrobial resistance

UK launches fresh fight against antimicrobial resistance

02-07-2014

The UK prime minister David Cameron has said he wants Britain to lead the way in the battle against antimicrobial…

Antibiotics and Infectious diseasesHealthcarePharmaceuticalUK

Thrombogenics’ Jetrea gains first Latin American approval in Uruguay

Thrombogenics’ Jetrea gains first Latin American approval in Uruguay

02-07-2014

Belgium-based biopharma firm ThromboGenics has said that Jetrea (ocriplasmin) has been approved in Uruguay…

JetreaOphthalmicsPharmaceuticalRegulationThromboGenicsUruguay

New entrants in chronic lymphocytic leukemia will raise market value to $3.3 billion by 2018

New entrants in chronic lymphocytic leukemia will raise market value to $3.3 billion by 2018

02-07-2014

The introduction of several new drugs will accelerate growth in the chronic lymphocytic leukemia treatment…

EuropeidelalisibImbruvicaMarkets & MarketingOncologyPharmaceuticalUSA

Medicines Australia submits new transparency reforms to ACCC

Medicines Australia submits new transparency reforms to ACCC

02-07-2014

Trade body Medicines Australia has applied for authorization of the 18th Edition of its Code of Conduct…

AustraliaPharmaceuticalRegulation

Roche to acquire Seragon in deal that could reach over $1.7 billion

Roche to acquire Seragon in deal that could reach over $1.7 billion

02-07-2014

Swiss drug major Roche says its USA-based biotech subsidiary Genentech has entered into a definitive…

BiotechnologyGenentechMergers & AcquisitionsOncologyRocheSeragon Pharmaceuticals

South Africa regulator gives MSF access to cheaper TB drug linezolid

South Africa regulator gives MSF access to cheaper TB drug linezolid

01-07-2014

After a three-year long struggle, humanitarian aid agency Medecins Sans Frontieres has received approval…

Antibiotics and Infectious diseasesGenericsHealthcareLinezolidPfizerRegulationSouth AfricaZyvox

Breakthrough status for Amgen’s blinatumomab in ALL

01-07-2014

USA-based Amgen, the world's largest independent biotech firm, says that the US Food and Drug Administration…

AmgenBiotechnologyblinatumomabOncologyRegulationUSA

76 to 100 of 8761 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top